ZFIN ID: ZDB-PUB-170218-11
Transcriptional and Behavioral Responses of Zebrafish Larvae to Microcystin-LR Exposure
Tzima, E., Serifi, I., Tsikari, I., Alzualde, A., Leonardos, I., Papamarcaki, T.
Date: 2017
Source: International Journal of Molecular Sciences 18(2): (Journal)
Registered Authors: Alzualde, Ainhoa, Papamarcaki, Thomais, Serifi, Iliana
Keywords: MCLR, behavior, gene expression, visual cycle, zebrafish
Microarrays: GEO:GSE73739
MeSH Terms:
  • Animals
  • Behavior, Animal/drug effects*
  • Gene Expression Profiling
  • Gene Expression Regulation/drug effects
  • Larva/drug effects*
  • Larva/genetics*
  • Microcystins/pharmacology*
  • Phosphorylation
  • Protein Phosphatase 2/metabolism
  • Transcription, Genetic/drug effects*
  • Zebrafish/genetics*
PubMed: 28208772 Full text @ Int. J. Mol. Sci.
Microcystins are cyclic heptapeptides that constitute a diverse group of toxins produced by cyanobacteria. One of the most toxic variants of this family is microcystin-LR (MCLR) which is a potent inhibitor of protein phosphatase 2A (PP2A) and induces cytoskeleton alterations. In this study, zebrafish larvae exposed to 500 μg/L of MCLR for four days exhibited a 40% reduction of PP2A activity compared to the controls, indicating early effects of the toxin. Gene expression profiling of the MCLR-exposed larvae using microarray analysis revealed that keratin 96 (krt96) was the most downregulated gene, consistent with the well-documented effects of MCLR on cytoskeleton structure. In addition, our analysis revealed upregulation in all genes encoding for the enzymes of the retinal visual cycle, including rpe65a (retinal pigment epithelium-specific protein 65a), which is critical for the larval vision. Quantitative real-time PCR (qPCR) analysis confirmed the microarray data, showing that rpe65a was significantly upregulated at 50 μg/L and 500 μg/L MCLR in a dose-dependent manner. Consistent with the microarray data, MCLR-treated larvae displayed behavioral alterations such as weakening response to the sudden darkness and hypoactivity in the dark. Our work reveals new molecular targets for MCLR and provides further insights into the molecular mechanisms of MCLR toxicity during early development.